{"id":849,"date":"2020-06-20T13:20:42","date_gmt":"2020-06-20T13:20:42","guid":{"rendered":"http:\/\/bxta-staging.website\/?page_id=849"},"modified":"2020-06-20T13:30:20","modified_gmt":"2020-06-20T13:30:20","slug":"ascende-rt-study","status":"publish","type":"page","link":"https:\/\/bxta.com\/de\/patient-information\/ascende-rt-study\/","title":{"rendered":"ASCENDE-RT Study"},"content":{"rendered":"
\n

The ASCENDE-RT Study<\/h3><\/div><\/div>\n\n\n\n

Intermediate and high-risk prostate cancer patients have double the survival chance with brachytherapy seeds<\/p>\n\n\n\n

\n
<\/div>
Read Study<\/a><\/a><\/div><\/div><\/div>\n\n\n\n
<\/div>
Protocol<\/a><\/a><\/div><\/div><\/div>\n\n\n\n
<\/div>
ASCENDE-RT data sheet Protocol<\/a><\/a><\/div><\/div><\/div>\n\n\n\n
<\/div>
Comment by Sree Rodda<\/a><\/div><\/div><\/div>\n<\/div><\/div><\/div>\n\n\n\n

BXTAccelyon Limited, the UK-based brachytherapy company supplying seeds, loaded needle assemblies and associated accessories and equipment to hospitals and clinics worldwide has called for an early review of the availability of seed brachytherapy for patients with intermediate and high-risk prostate cancer.<\/p>\n\n\n\n

Low Dose Rate (LDR) Brachytherapy is a form of radiation therapy that involves placing tiny radioactive \u201cseeds\u201d directly into the prostate. The ASCENDE-RT study from Canada, is a randomized trial comparing the use of dose-escalated external beam radiation therapy (DE-EBRT) and low-dose-rate-brachytherapy (LDR-B) in men with intermediate- and high-risk prostate cancer. In summary, the trial demonstrated a 50% decrease in biochemical relapse with the use of LDR-B in conjunction with hormones and whole pelvis radiotherapy when compared to using DE-EBRT with the same treatments in patients randomly assigned to the two forms of treatment.<\/p>\n\n\n\n

In the UK and Ireland, around 45,000 new prostate cancer cases are diagnosed annually and two-thirds of these patients have early stage disease which is suitable for LDR brachytherapy treatment. Currently, over 1,500 patients receive brachytherapy seed treatment annually at 36 centres in the UK & Ireland. In Australia and New Zealand around 23,000 new prostate cancer cases are diagnosed annually and over two-thirds of these patients have early stage disease which is suitable for LDR brachytherapy treatment.<\/p>\n\n\n\n

Saheed Rashid, Gesch\u00e4ftsf\u00fchrer von BXTAccelyon, hierzu: \u201eDiese Art Information kann Klinik\u00e4rzten und Beauftragten im Gesundheitswesen dabei helfen, die besten Behandlungen f\u00fcr Patienten mit Prostatakrebs zu ermitteln und ihnen anzubieten. Die Studie ist extrem wertvoll, da sie deutlich macht, dass eine \u00c4nderung der klinischen Praxis notwendig ist, um M\u00e4nnern mit dieser Art Krankheit Zugang zu einer Behandlung zu erm\u00f6glichen, die ihnen eine f\u00fcnfzigprozentig bessere Chance gibt, langfristig krankheitsfrei zu bleiben. Abgesehen von der Einfachheit und den kostensparenden Vorteilen der Seed-Brachytherapie als Behandlungsoption ist diese Studie auch aufgrund der \u201eFreisetzung\u201c wertvoller Zeit an den f\u00fcr die Strahlentherapie verwendeten Maschinen von enormer Bedeutung, und zwar nicht nur f\u00fcr Prostatakrebspatienten, sondern auch f\u00fcr Patienten mit anderen Krebsarten, die oft lange auf eine Behandlung an den gleichen Maschinen warten m\u00fcssen.\u201c<\/p>\n\n\n\n

F\u00fcr mehr Informationen wenden Sie sich bitte an:<\/p>\n<\/div><\/div><\/div>\n\n\n\n

\n

Saheed Rashid<\/strong> – Gesch\u00e4ftsf\u00fchrer<\/em><\/p>\n\n\n\n

E: saheed.rashid@bxt-accelyon.com<\/p>\n\n\n\n

T: +44(0)7979-327526<\/p>\n\n\n\n

www.bxt-accelyon.com<\/a><\/p>\n<\/div><\/div><\/div>\n\n\n\n

<\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":242,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-849","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nASCENDE-RT Study - BXTA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bxta.com\/de\/patient-information\/ascende-rt-study\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASCENDE-RT Study - BXTA\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bxta.com\/de\/patient-information\/ascende-rt-study\/\" \/>\n<meta property=\"og:site_name\" content=\"BXTA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/bxtainternational\/\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-20T13:30:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bxta-staging.website\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-20-at-14.20.14.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BXTA_\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/\",\"url\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/\",\"name\":\"ASCENDE-RT Study - BXTA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/bxta-staging.website\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-20-at-14.20.14.png\",\"datePublished\":\"2020-06-20T13:20:42+00:00\",\"dateModified\":\"2020-06-20T13:30:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/#primaryimage\",\"url\":\"https:\\\/\\\/bxta-staging.website\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-20-at-14.20.14.png\",\"contentUrl\":\"https:\\\/\\\/bxta-staging.website\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Screenshot-2020-06-20-at-14.20.14.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/ascende-rt-study\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/bxta.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Patient Information\",\"item\":\"https:\\\/\\\/bxta.com\\\/patient-information\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ASCENDE-RT Study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#website\",\"url\":\"https:\\\/\\\/bxta.com\\\/uk\\\/\",\"name\":\"BXTA\",\"description\":\"Let\u2019s tackle Prostate Cancer together | BXTA\",\"publisher\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/bxta.com\\\/uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#organization\",\"name\":\"BXTA\",\"url\":\"https:\\\/\\\/bxta.com\\\/uk\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/bxta-staging.s3.eu-west-2.amazonaws.com\\\/app\\\/uploads\\\/2021\\\/09\\\/07212056\\\/BXTA-Logo.png\",\"contentUrl\":\"https:\\\/\\\/bxta-staging.s3.eu-west-2.amazonaws.com\\\/app\\\/uploads\\\/2021\\\/09\\\/07212056\\\/BXTA-Logo.png\",\"width\":600,\"height\":373,\"caption\":\"BXTA\"},\"image\":{\"@id\":\"https:\\\/\\\/bxta.com\\\/uk\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/bxtainternational\\\/\",\"https:\\\/\\\/x.com\\\/BXTA_\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/bxtaccelyon\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCkTU9L10CS5c1eWtGiMZ7gw\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ASCENDE-RT Study - BXTA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bxta.com\/de\/patient-information\/ascende-rt-study\/","og_locale":"de_DE","og_type":"article","og_title":"ASCENDE-RT Study - BXTA","og_url":"https:\/\/bxta.com\/de\/patient-information\/ascende-rt-study\/","og_site_name":"BXTA","article_publisher":"https:\/\/www.facebook.com\/bxtainternational\/","article_modified_time":"2020-06-20T13:30:20+00:00","og_image":[{"url":"https:\/\/bxta-staging.website\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-20-at-14.20.14.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@BXTA_","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/","url":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/","name":"ASCENDE-RT Study - BXTA","isPartOf":{"@id":"https:\/\/bxta.com\/uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/#primaryimage"},"image":{"@id":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/#primaryimage"},"thumbnailUrl":"https:\/\/bxta-staging.website\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-20-at-14.20.14.png","datePublished":"2020-06-20T13:20:42+00:00","dateModified":"2020-06-20T13:30:20+00:00","breadcrumb":{"@id":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bxta.com\/patient-information\/ascende-rt-study\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/#primaryimage","url":"https:\/\/bxta-staging.website\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-20-at-14.20.14.png","contentUrl":"https:\/\/bxta-staging.website\/wp-content\/uploads\/2020\/06\/Screenshot-2020-06-20-at-14.20.14.png"},{"@type":"BreadcrumbList","@id":"https:\/\/bxta.com\/patient-information\/ascende-rt-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bxta.com\/"},{"@type":"ListItem","position":2,"name":"Patient Information","item":"https:\/\/bxta.com\/patient-information\/"},{"@type":"ListItem","position":3,"name":"ASCENDE-RT Study"}]},{"@type":"WebSite","@id":"https:\/\/bxta.com\/uk\/#website","url":"https:\/\/bxta.com\/uk\/","name":"BXTA","description":"Let\u2019s tackle Prostate Cancer together | BXTA","publisher":{"@id":"https:\/\/bxta.com\/uk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bxta.com\/uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/bxta.com\/uk\/#organization","name":"BXTA","url":"https:\/\/bxta.com\/uk\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/bxta.com\/uk\/#\/schema\/logo\/image\/","url":"https:\/\/bxta-staging.s3.eu-west-2.amazonaws.com\/app\/uploads\/2021\/09\/07212056\/BXTA-Logo.png","contentUrl":"https:\/\/bxta-staging.s3.eu-west-2.amazonaws.com\/app\/uploads\/2021\/09\/07212056\/BXTA-Logo.png","width":600,"height":373,"caption":"BXTA"},"image":{"@id":"https:\/\/bxta.com\/uk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/bxtainternational\/","https:\/\/x.com\/BXTA_","https:\/\/www.linkedin.com\/company\/bxtaccelyon","https:\/\/www.youtube.com\/channel\/UCkTU9L10CS5c1eWtGiMZ7gw"]}]}},"_links":{"self":[{"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/pages\/849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/comments?post=849"}],"version-history":[{"count":7,"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/pages\/849\/revisions"}],"predecessor-version":[{"id":860,"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/pages\/849\/revisions\/860"}],"up":[{"embeddable":true,"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/pages\/242"}],"wp:attachment":[{"href":"https:\/\/bxta.com\/de\/wp-json\/wp\/v2\/media?parent=849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}